Literature DB >> 23839139

The case for semi-mandatory HPV vaccination in China.

Wen Jie Zhang, Feng Li, Ying Hong Wang, Dilixia Simayi, Abudukeyoumu Saimaiti, Xiao Guang Zou, Cheng Liang Xiong, Fei Li Gong, Yu Guang Cao.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23839139     DOI: 10.1038/nbt.2631

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

1.  Recommended adult immunization schedule: United States, 2012.

Authors: 
Journal:  Ann Intern Med       Date:  2012-01-31       Impact factor: 25.391

2.  Adult immunization 2012: politics, process, and progress.

Authors:  Sandra Adamson Fryhofer
Journal:  Ann Intern Med       Date:  2012-01-31       Impact factor: 25.391

Review 3.  Early appraisal of China's huge and complex health-care reforms.

Authors:  Winnie Chi-Man Yip; William C Hsiao; Wen Chen; Shanlian Hu; Jin Ma; Alan Maynard
Journal:  Lancet       Date:  2012-03-03       Impact factor: 79.321

4.  Mandatory HPV vaccination and political debate.

Authors:  Lawrence O Gostin
Journal:  JAMA       Date:  2011-10-06       Impact factor: 56.272

5.  Introducing HPV vaccine in developing countries--key challenges and issues.

Authors:  Jan M Agosti; Sue J Goldie
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

Review 6.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 7.  Review of the cervical cancer disease burden in mainland China.

Authors:  Jing Li; Le-Ni Kang; You-Lin Qiao
Journal:  Asian Pac J Cancer Prev       Date:  2011

8.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  8 in total
  14 in total

1.  Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 expression in patients with breast cancer.

Authors:  Nan Zhang; Zhi Ping Ma; Ju Wang; Hui Li Bai; Yi Xin Li; Qin Sun; Lan Yang; Lin Tao; Jin Zhao; Yu Wen Cao; Feng Li; Wen Jie Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

2.  How university students view human papillomavirus (HPV) vaccination: A cross-sectional study in Jinan, China.

Authors:  Huachun Zou; Wei Wang; Yuanyuan Ma; Yongjie Wang; Fanghui Zhao; Shaoming Wang; Shaokai Zhang; Wei Ma
Journal:  Hum Vaccin Immunother       Date:  2015-08-26       Impact factor: 3.452

3.  Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China.

Authors:  Zhenwei Dai; Mingyu Si; Xiaoyou Su; Wenjun Wang; Xi Zhang; Xiaofen Gu; Li Ma; Jing Li; Shaokai Zhang; Zefang Ren; Youlin Qiao
Journal:  J Med Virol       Date:  2021-12-06       Impact factor: 20.693

4.  Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer.

Authors:  Yi Xin Li; Lei Zhang; Dilixia Simayi; Nan Zhang; Lin Tao; Lan Yang; Jin Zhao; Yun Zhao Chen; Feng Li; Wen Jie Zhang
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Ethnic differences in prevalence of general obesity and abdominal obesity among low-income rural Kazakh and Uyghur adults in far western China and implications in preventive public health.

Authors:  Jia He; Shuxia Guo; Jiaming Liu; Mei Zhang; Yusong Ding; Jingyu Zhang; Shugang Li; Shangzhi Xu; Qiang Niu; Heng Guo; Rulin Ma
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

6.  Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China.

Authors:  Shuxia Guo; Yunhua Hu; Yusong Ding; Jiaming Liu; Mei Zhang; Rulin Ma; Heng Guo; Kui Wang; Jia He; Yizhong Yan; Dongsheng Rui; Feng Sun; Lati Mu; Qiang Niu; Jingyu Zhang; Shugang Li
Journal:  Int J Environ Res Public Health       Date:  2015-12-16       Impact factor: 3.390

7.  Prevalence of Hypertension among Adults in Remote Rural Areas of Xinjiang, China.

Authors:  Yulin Wang; Jingyu Zhang; Yusong Ding; Mei Zhang; Jiaming Liu; Jiaolong Ma; Heng Guo; Yizhong Yan; Jia He; Kui Wang; Shugang Li; Rulin Ma; Bek Murat; Shuxia Guo
Journal:  Int J Environ Res Public Health       Date:  2016-05-24       Impact factor: 3.390

8.  The Optimal Ethnic-Specific Waist-Circumference Cut-Off Points of Metabolic Syndrome among Low-Income Rural Uyghur Adults in Far Western China and Implications in Preventive Public Health.

Authors:  Jia He; Rulin Ma; Jiaming Liu; Mei Zhang; Yusong Ding; Heng Guo; Lati Mu; Jingyu Zhang; Bin Wei; Yizhong Yan; Jiaolong Ma; Hongrui Pang; Shugang Li; Shuxia Guo
Journal:  Int J Environ Res Public Health       Date:  2017-02-08       Impact factor: 3.390

9.  Association of Inflammation with Metabolic Syndrome among Low-Income Rural Kazakh and Uyghur Adults in Far Western China.

Authors:  Yi-Zhong Yan; Ru-Lin Ma; Yu-Song Ding; Heng Guo; Jing-Yu Zhang; La-Ti Mu; Mei Zhang; Jia-Ming Liu; Dong-Sheng Rui; Jia He; Feng Sun; Kui Wang; Shu-Xia Guo
Journal:  Mediators Inflamm       Date:  2015-07-01       Impact factor: 4.711

10.  Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health.

Authors:  Li Cong; Jin Qiong Zhan; Lan Yang; Wei Zhang; Shu Gang Li; Cheng Chen; Hong Yan Zhang; Zhi Ping Ma; Xiao Ling Hao; Dilixia Simayi; Lin Tao; Jin Zhao; A Amanguli; Meiliguli Mohemaiti; Ming Xia Jing; Wei Wang; Abudukeyoumu Saimaiti; Xiao Guang Zou; Yan Gu; Li Li; Ying Hong Wang; Feng Li; Wen Jie Zhang
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.